Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...

At 7 years old, Morgan Barrett was diagnosed with cystic fibrosis. Prior to her diagnosis, she struggled to gain weight ...

My son was diagnosed with CF in 1965 and bravely defied the odds, living 28 cherished years. Then, decades later, I was stunned to receive a CF diagnosis of my own.

Children and adults with rare forms of cystic fibrosis in England will be able to access triple-combination therapy. Vanzacaftor–tezacaftor–deutivacaftor (Alyftrek®), is the latest in a new generation ...

The Cystic Fibrosis Foundation has agreed to provide Prime Medicine Inc. an additional investment of up to $24 million to ...

Licensed for use in the UK in March, Alyftrek will now be immediately funded by the NHS in England. This rapid timeline demonstrates NICE's commitment to getting breakthrough treatments to patients ...

Individuals with cystic fibrosis or CFTR gene variants have a 3-fold higher risk of developing pancreatic cancer after 50 years of age.

Latest studies show Us pharma giant Vertex's new CF wonder pill Alyftrek has shown better results than their currently available drug Kaftrio.

Trikafta has transformed my life in ways I never thought possible. But with that came a sharp awareness of those still waiting for a treatment that works for them. That’s why I’m deeply committed to ...

Cystic fibrosis (CF) is typically described as one of the most common lethal autosomal recessive disorders in North America. 1 About 1 in 25–30 Caucasians are carriers of CF mutations, whereas ...

Cystic fibrosis (CF) caused by a gene that doesn’t work properly. Learn what genetic testing can tell you about this faulty gene, and what your next steps may be.